Beta 2 Glycoprotein I IgM Test: Booking, Price, and Results
About Beta 2 Glycoprotein I IgM Test: Booking, Price, and Results
| Field | Value |
|---|---|
| Also Known As | Anti-Beta-2 Glycoprotein 1 IgM, β2GP1 IgM, Anti-β2GPI IgM, Beta-2 Glycoprotein I Antibody IgM, β2-Glycoprotein 1 Antibodies IgM |
| Sample Type | Venous blood (serum) |
| Fasting Required | No fasting required |
| Report Time | Within 6 working days |
| Recommended For | Adults of all genders; particularly women with a history of recurrent miscarriages or blood clots |
| Price | Starting at ₹920 |
What Is a Beta 2 Glycoprotein I IgM Test?
The beta 2 glycoprotein I IgM test checks for a specific type of autoantibody in your blood. An autoantibody is a protein that your immune system mistakenly produces against your own body's tissues. This particular antibody targets a protein called beta-2 glycoprotein I, which is found on cell membranes and platelets, and is linked to abnormal blood clotting.
Doctors commonly order this anti-beta-2 glycoprotein 1 IgM test when they suspect antiphospholipid syndrome (APS) or related autoimmune conditions. It is also known as the β2GP1 IgM test or the beta-2 glycoprotein I antibody IgM test. A small blood sample drawn from a vein in your arm is all that is needed.
What Does a Beta 2 Glycoprotein I IgM Test Measure?
This test detects and measures the level of IgM-type antibodies directed against beta-2 glycoprotein I in your blood serum. IgM antibodies are typically the first type of antibody the body produces when it encounters a new infection or autoimmune trigger, making them an early marker of immune activity.
The table below summarises what this test measures and why it matters.
| Parameter | What It Represents |
|---|---|
| Beta-2 Glycoprotein I IgM Antibodies | Autoantibodies that target a lipid-binding protein on platelets and cell membranes. Their presence is associated with an increased risk of blood clots and pregnancy complications. |
Why Is a Beta 2 Glycoprotein I IgM Test Done?
Your doctor may request this test for several reasons, ranging from unexplained blood clotting to recurrent pregnancy loss.
Common Symptoms That May Require This Test
- Swelling, pain, or redness in the legs, which may suggest a blood clot
- Sudden breathlessness or chest pain without a clear cause
- A history of repeated miscarriages or stillbirths
- Stroke or transient ischaemic attack (a brief episode of neurological symptoms)
- Abnormally high blood pressure during pregnancy (preeclampsia)
- Unexplained low platelet count (thrombocytopenia)
- Diagnosed autoimmune conditions such as lupus
Conditions This Test Can Help Detect
- Antiphospholipid syndrome (APS), a disorder involving blood clots in vessels and pregnancy-related complications
- Secondary APS associated with systemic lupus erythematosus (SLE)
- Unexplained arterial or venous thrombosis (clotting in arteries or veins)
- Recurrent pregnancy loss or foetal complications linked to autoimmune activity
Beta 2 Glycoprotein I IgM Test During Pregnancy
This test plays an important role in pregnancy care. Around 10 to 15% of women who experience recurrent miscarriages are found to have antiphospholipid syndrome. Pregnancy loss at or after 10 weeks of gestation is more closely linked to antiphospholipid antibodies than earlier losses.
APS is now recognised as one of the most common treatable causes of recurrent miscarriage. When correctly identified and managed, pregnancy success rates have improved significantly, rising from around 20% before 1990 to approximately 70 to 80% today.
Beta 2 Glycoprotein I IgM Test for Chronic Disease Monitoring
For patients already diagnosed with APS or SLE, this test is repeated at regular intervals to check whether antibodies persist over time. According to established diagnostic criteria, antibodies must be detected on at least two separate occasions, at least 12 weeks apart, to confirm a diagnosis of definite APS.
Ongoing monitoring helps a doctor assess whether the condition is stable and whether any related complications are developing.
How to Prepare and What to Expect
No special preparation is needed for this test, but a few simple steps will help ensure a smooth experience.
Do You Need to Fast?
No, fasting is not required before the beta 2 glycoprotein I IgM test. You can eat and drink normally on the day of your appointment. If your doctor has also ordered other tests at the same time, check whether those require fasting.
Practical Tips Before Your Test
- Avoid getting the test done if you currently have an active infection or fever, as this can temporarily raise antibody levels and affect results
- Tell your doctor about all medications you are taking, particularly blood thinners (anticoagulants), penicillin, anti-seizure medicines such as phenytoin, or procainamide
- If you are pregnant, inform both your doctor and the collection team before the test
- Drink enough water before your appointment, as good hydration makes the blood draw easier
Step-by-Step Procedure
- A trained phlebotomist (a specialist in drawing blood) will ask you to sit comfortably and extend your arm
- They will clean a small area of skin on the inside of your arm with an antiseptic swab
- A fine needle is used to draw a small amount of blood into a specialised collection tube
- The collected sample is processed promptly, with serum separated from blood cells within about two hours
- The tube is labelled and packed carefully for transport to the laboratory
- At the lab, the sample is tested using ELISA (Enzyme-Linked Immunosorbent Assay), a method used to detect specific antibodies in blood
Factors That Can Affect Accuracy
Several factors may influence your test result. These include:
- Active infections, HIV/AIDS, or certain cancers, which can cause temporary antibody production
- Medications such as phenytoin, penicillin, and procainamide
- Natural fluctuations in antibody levels over time
- Differences between testing methods used across laboratories
Understanding Your Beta 2 Glycoprotein I IgM Test Results
Results from this test should always be reviewed with your doctor, who will consider them alongside your symptoms, medical history, and any other tests you have had. The table below provides a general guide to result interpretation.
| Result Category | Range (SMU) | General Meaning |
|---|---|---|
| Negative | Less than 15.0 | No significant antibody detected |
| Weakly Positive | 15.0 to 39.9 | Low-level antibody presence; repeat testing may be needed |
| Positive | 40.0 to 79.9 | Antibody detected at a level meeting diagnostic thresholds |
| Strongly Positive | 80.0 and above | High antibody level; warrants clinical evaluation |
SMU = Standard IgM Beta-2 Glycoprotein Unit. A result of 20.00 SMU or above exceeds the 99th percentile threshold as defined by the Sapporo criteria for APS diagnosis.
These ranges are general guidelines. Your doctor will interpret your results based on your age, health history, and other factors. Always consult a qualified healthcare professional for personalised medical advice.
Results During Special Conditions
- A one-time positive result does not confirm APS. If antibodies are detected, the test is repeated after 12 weeks. A negative result on repeat testing suggests the antibodies were temporary, possibly due to an infection, certain medications, or another short-term cause.
- In patients with SLE, a positive result may indicate a higher risk of developing blood clots or secondary APS.
- Unlike anticardiolipin antibodies, beta-2 glycoprotein I autoantibodies are found almost exclusively in autoimmune conditions rather than in infectious diseases.
How to Maintain Healthy Levels
While lifestyle changes cannot directly alter autoantibody levels, the following habits support overall vascular health:
- Eat a balanced diet and keep physically active to support healthy blood flow
- Avoid smoking, as tobacco use raises the risk of blood clots in people with autoimmune conditions
- During long periods of sitting, such as on flights or car journeys, move your legs regularly and flex your ankles to encourage circulation
Lupin Diagnostics Beta 2 Glycoprotein I IgM Test Price and Home Collection
The beta-2 glycoprotein I IgM test price starts at approximately ₹920, with home collection available across major Indian cities. The city-wise price estimates below are sourced from aggregator data.
| City | Approximate Price (₹) |
|---|---|
| Mumbai | ₹920 |
| Bhopal | ₹920 |
| Chennai | ₹920 |
| Bangalore | ₹920 |
| Hyderabad | ₹920 |
| Kolkata | ₹920 |
| Pune | ₹920 |
| Indore | ₹920 |
Prices are indicative and may vary by location. Please confirm the current price at the time of booking.
How to Book
- Select the test on the Lupin Diagnostics website
- Choose your city and preferred time slot
- Opt for home sample collection by a certified phlebotomist, or visit your nearest Lupin Diagnostics centre
- Receive your report via email or WhatsApp within the stipulated turnaround time
Home Collection
Lupin Diagnostics offers home sample collection for the beta 2GP1 antibody test across cities in India. All samples are processed in NABL-accredited laboratories by experienced professionals. Your digital report is delivered to you via email or WhatsApp, with no need for a clinic visit to collect results.
Frequently Asked Questions
IgM antibodies are the first type the body produces when responding to a new infection or autoimmune trigger. IgG antibodies typically appear later and may reflect a more established immune response. Both types are usually tested together when APS is suspected, as both form part of the diagnostic criteria.
A single positive result is not enough to diagnose APS. The antibodies must be detected on at least two separate occasions, at least 12 weeks apart. This repeat testing confirms that the antibodies are persistent rather than a temporary response to an infection or medication.
Yes, infections such as HIV/AIDS, certain acute illnesses, and some cancers can temporarily raise antiphospholipid antibody IgM levels. Some medications, including phenytoin and penicillin, may also do so. This is one of the key reasons why repeat testing after 12 weeks is essential before any diagnosis is confirmed.
Yes. Women who have experienced repeated miscarriages or pregnancy complications may be tested, as APS is one of the most common and treatable causes of recurrent pregnancy loss. Foetal loss at or after 10 weeks of gestation has a particularly strong association with antiphospholipid antibodies.
Doctors often request additional tests at the same time to build a complete picture. These typically include anticardiolipin antibodies and the lupus anticoagulant profile, as all three form part of the recognised laboratory criteria for diagnosing APS. Your doctor will advise on the specific combination appropriate for your situation.
Not necessarily. A positive result indicates an increased risk, but it does not confirm that blood clots will occur, nor does it predict how often or how severely they might occur. Your doctor will assess your overall health picture and discuss any steps that may be appropriate for you.
Detection of beta-2 glycoprotein I IgM antibodies using ELISA and similar solid-phase immunoassay methods is generally not affected by anticoagulant (blood-thinning) treatment. That said, always inform your doctor and the collection team about every medication you are taking before the β2GP1 IgM test or at a centre.
Beta 2 Glycoprotein I IgM Test: Booking, Price, and Results
